Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
  1. DEFA14A Proxy Proxy Materials
  2. EFFECT Other Notice of Effectiveness
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  6. FWP Offering Free Writing Prospectus
  7. EFFECT Other Notice of Effectiveness
  8. CERT Other Certification
  9. 8-A12B Other Registration of Securities
  10. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  11. DRSLTR Other Correspondence Related to Draft Registration Statement
  12. DRS/A Other Draft Registration Statement
  13. DRS/A Other Draft Registration Statement
  14. DRSLTR Other Correspondence Related to Draft Registration Statement
  15. DRSLTR Other Correspondence Related to Draft Registration Statement
  16. DRS/A Other Draft Registration Statement
  17. DRSLTR Other Correspondence Related to Draft Registration Statement
  18. DRS/A Other Draft Registration Statement
  19. DRS Other Draft Registration Statement

Page 4 of 4 · 79 filings